XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Capital in Excess of Par Value
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance (in shares) at Nov. 02, 2019   368,302          
Beginning Balance at Nov. 02, 2019   $ 61,385 $ 4,936,349 $ 6,899,253 $ 2,379 $ (187,799) $ (2,379)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income $ 1,220,761     1,220,761      
Dividends declared and paid       (886,155)      
Issuance of stock under stock plans and other (in shares)   3,110          
Issuance of stock under stock plans and other   $ 518 67,885        
Issuance of stock as charitable contribution (in shares)   336          
Issuance of stock as charitable contribution   $ 56 39,944        
Stock-based compensation expense     149,518        
Other comprehensive income (loss)           (59,283)  
Common stock repurchased (in shares)   (2,263)          
Common stock repurchased   $ (377) (244,110)        
Ending Balance (in shares) at Oct. 31, 2020   369,485          
Ending Balance at Oct. 31, 2020   $ 61,582 4,949,586 7,236,238   (249,461)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,390,422     1,390,422      
Dividends declared and paid       (1,109,344)      
Issuance of stock under stock plans and other (in shares)   2,738          
Issuance of stock under stock plans and other   $ 355 62,750        
Issuance of stock in connection with Acquisition (in shares)   169,233          
Issuance of stock in connection with Acquisition   $ 28,204 27,725,957        
Stock-based compensation expense     243,611        
Replacement share-based awards issued in connection with Acquisition     194,890        
Other comprehensive income (loss)           62,896  
Common stock repurchased (in shares)   (16,125)          
Common stock repurchased   $ (2,587) (2,602,557)        
Ending Balance (in shares) at Oct. 30, 2021   525,331          
Ending Balance at Oct. 30, 2021 37,992,542 $ 87,554 30,574,237 7,517,316   (186,565)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 2,748,561     2,748,561      
Dividends declared and paid       (1,544,552)      
Issuance of stock under stock plans and other (in shares)   2,701          
Issuance of stock under stock plans and other   $ 449 33,438        
Stock-based compensation expense     323,487        
Other comprehensive income (loss)           (11,587)  
Common stock repurchased (in shares)   (18,736)          
Common stock repurchased   $ (3,123) (3,073,892)        
Ending Balance (in shares) at Oct. 29, 2022   509,296          
Ending Balance at Oct. 29, 2022 $ 36,465,323 $ 84,880 $ 27,857,270 $ 8,721,325   $ (198,152)